Literature DB >> 31439661

Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.

Hongju Zhang1, Edward A El-Am1, Jeremy J Thaden1, Sorin V Pislaru1, Christopher G Scott2, Chayakrit Krittanawong1, Anwar A Chahal1, Thomas J Breen3, Mackram F Eleid1, Rowlens M Melduni1, Kevin L Greason4, Robert B McCully1, Maurice Enriquez-Sarano1, Jae K Oh1, Patricia A Pellikka1, Vuyisile T Nkomo5.   

Abstract

OBJECTIVES: To examine the prognostic significance of atrial fibrillation (AF) versus sinus rhythm (SR) on the management and outcomes of patients with severe aortic stenosis (AS).
METHODS: 1847 consecutive patients with severe AS (aortic valve area ≤1.0 cm2 and aortic valve systolic mean Doppler gradient ≥40 mm Hg or peak velocity ≥4 m/s) and left ventricular ejection fraction ≥50% were identified. The independent association of AF and all-cause mortality was assessed.
RESULTS: Age was 76±11 years and 46% were female; 293 (16%) patients had AF and 1554 (84%) had SR. In AF, 72% were symptomatic versus 71% in SR. Survival rate at 5 years for AF (41%) was lower than SR (65%) (age- and sex-adjusted HR=1.66 (1.40-1.98), p<0.0001). In multivariable analysis, factors associated with mortality included age (HR per 10 years=1.55 (1.42-1.69), p<0.0001), dyspnoea (HR=1.58 (1.33-1.87), p<0.0001), ≥ moderate mitral regurgitation (HR=1.63 (1.22-2.18), p=0.001), right ventricular systolic dysfunction (HR=1.88 (1.52-2.33), p<0.0001), left atrial volume index (HR per 10 mL/m2=1.13 (1.07-1.19), p<0.0001) and aortic valve replacement (AVR) (HR=0.44 (0.38-0.52), p<0.0001). AF was not a predictor of mortality independent of variables strongly correlated HR=1.02 (0.84-1.25), p=0.81). The 1-year probability of AVR following diagnosis of severe AS was lower in AF (49.8%) than SR (62.5%) (HR=0.73 (0.62-0.86), p<0.001); among patients with AF not referred for AVR, symptoms were frequently attributed to AF instead of AS.
CONCLUSION: AF was associated with poor prognosis in patients with severe AS, but apparent differences in outcomes compared with SR were explained by factors other than AF including concomitant cardiac abnormalities and deferral of AVR due to attribution of cardiac symptoms to AF. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  aortic stenosis; aortic valve replacement; atrial fibrillation; mortality; natural history; prognosis

Mesh:

Year:  2019        PMID: 31439661      PMCID: PMC6989366          DOI: 10.1136/heartjnl-2019-314996

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Unoperated patients with severe aortic stenosis.

Authors:  David S Bach; Nina Cimino; G Michael Deeb
Journal:  J Am Coll Cardiol       Date:  2007-10-29       Impact factor: 24.094

2.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.

Authors:  Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Arturo Evangelista; Brian P Griffin; Bernard Iung; Catherine M Otto; Patricia A Pellikka; Miguel Quiñones
Journal:  J Am Soc Echocardiogr       Date:  2009-01       Impact factor: 5.251

3.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2016-04       Impact factor: 5.251

4.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

5.  Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

Authors:  Charles R Kerr; Karin H Humphries; Mario Talajic; George J Klein; Stuart J Connolly; Martin Green; John Boone; Robert Sheldon; Paul Dorian; David Newman
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

6.  Prevalence of comorbidities and associated cardiac diseases in patients with valve aortic stenosis. Potential implications for the decision-making process.

Authors:  Pompilio Faggiano; Silvia Frattini; Valentina Zilioli; Andrea Rossi; Stefano Nistri; Frank L Dini; Roberto Lorusso; Cesare Tomasi; Livio Dei Cas
Journal:  Int J Cardiol       Date:  2011-03-03       Impact factor: 4.164

7.  Decade-long trends in atrial fibrillation incidence and survival: a community study.

Authors:  Alanna M Chamberlain; Bernard J Gersh; Alvaro Alonso; Lin Y Chen; Cecilia Berardi; Sheila M Manemann; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  Am J Med       Date:  2014-11-08       Impact factor: 4.965

8.  Determinants and prognosis of atrial fibrillation in patients with aortic stenosis.

Authors:  Franck Levy; Dan Rusinaru; Sylvestre Maréchaux; Vincent Charles; Marcel Peltier; Christophe Tribouilloy
Journal:  Am J Cardiol       Date:  2015-09-01       Impact factor: 2.778

9.  Left Atrial Volume and Mortality in Patients With Aortic Stenosis.

Authors:  Dan Rusinaru; Yohann Bohbot; Cédric Kowalski; Anne Ringle; Sylvestre Maréchaux; Christophe Tribouilloy
Journal:  J Am Heart Assoc       Date:  2017-10-31       Impact factor: 5.501

10.  Aortic stenosis and mitral regurgitation as predictors of atrial fibrillation during 11 years of follow-up.

Authors:  Veronica Widgren; Magnus Dencker; Tord Juhlin; Pyotr Platonov; Ronnie Willenheimer
Journal:  BMC Cardiovasc Disord       Date:  2012-10-18       Impact factor: 2.298

View more
  4 in total

1.  Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis.

Authors:  Line Melgaard; Thure Filskov Overvad; Martin Jensen; Thomas Decker Christensen; Gregory Y H Lip; Torben Bjerregaard Larsen; Peter Brønnum Nielsen
Journal:  J Am Heart Assoc       Date:  2021-11-24       Impact factor: 6.106

Review 2.  Advances in the Treatment of Cardiac Amyloidosis.

Authors:  Ariane Vieira Scarlatelli Macedo; Pedro Vellosa Schwartzmann; Breno Moreno de Gusmão; Marcelo Dantas Tavares de Melo; Otávio Rizzi Coelho-Filho
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

3.  Post-operative Atrial Fibrillation Impacts on Outcomes in Transcatheter and Surgical Aortic Valve Replacement.

Authors:  Hyung Ki Jeong; Namsik Yoon; Ju Han Kim; Nuri Lee; Dae Yong Hyun; Min Chul Kim; Ki Hong Lee; Yo Cheon Jeong; In Seok Jeong; Hyun Ju Yoon; Kye Hun Kim; Hyung Wook Park; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho
Journal:  Front Cardiovasc Med       Date:  2021-11-29

Review 4.  Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward.

Authors:  Maciej Kubala; Christian de Chillou; Yohann Bohbot; Patrizio Lancellotti; Maurice Enriquez-Sarano; Christophe Tribouilloy
Journal:  Front Cardiovasc Med       Date:  2022-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.